Optimizing Higher Throughput Methods to Assess Drug-Drug Interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 In Vitro Using a Single Point IC50

  • R. Daniel Meyer, Michael West, Feng Gao, Diane L. Johnson, Sean Ekins, John Janiszewski, Kevin G. Kelly
  • SLAS DISCOVERY Advancing the Science of Drug Discovery, August 2002, Mary Ann Liebert Inc
  • DOI: 10.1089/108705702320351231

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Sean Ekins